ODM-212 clinical trials

A Phase 1/2, First-in-Human Study On ODM-212 In Subjects With Selected Advanced Solid Tumours

This study is testing a new drug called ODM-212 for people with certain advanced solid cancers that haven't responded to other treatments. It aims to find the right dose and see if it helps. It's a first-time human study.